Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study

BACKGROUND: Cerebral malaria (CM) is associated with high mortality and morbidity caused by a high rate of transient or persistent neurological sequelae. Studies on immunomodulatory and neuroprotective drugs as ancillary treatment in murine CM indicate promising potential. The current study was cond...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lackner, Peter, Part, Andrea, Burger, Christoph, Dietmann, Anelia, Broessner, Gregor, Helbok, Raimund, Reindl, Markus, Schmutzhard, Erich, Beer, Ronny
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651188/
https://ncbi.nlm.nih.gov/pubmed/19250545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-8-36
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados